
For the Inventor. By the Inventor.
Hiring in 8 countries shouldn't require 8 different processes
This guide from Deel breaks down how to build one global hiring system. You’ll learn about assessment frameworks that scale, how to do headcount planning across regions, and even intake processes that work everywhere. As HR pros know, hiring in one country is hard enough. So let this free global hiring guide give you the tools you need to avoid global hiring headaches.
To ensure a streamlined reading experience, all source citations and deep-dive links are hosted exclusively in the full article on our blog. We use the Patent Strength scores to select our curated stories. Patent strength is the measure of a patent’s legal ability to survive a challenge and its strategic value in preventing competitors from commercially using an invention.
Table of Contents
Biotech & Healthcare
Energy & Materials
Aerospace & Defense
Retail, UX & Logistics
Recommendations
Want your company featured to 50,000 plus innovation-minded readers? Sponsor an IDiyas story. Please see our newsletter stats. Send us an email to: [email protected] for details.
💉 BIOTECH & HEALTHCARE
Patents in Motion: Assessing this week's highlighted tickers:
Intensity Therapeutics: The "Tumor-Melting" Cocktail
🔬 The Tech: U.S. Patent No. 12,496,345 (and related portfolio) covers INT230-6, a non-covalent drug conjugation that allows high concentrations of cisplatin and vinblastine to be injected directly into a tumor without leaking into the bloodstream.
🏋️♂️ Patent Strength: 9.4/10 (Newly granted US protection + validated in 41 countries).
🚀 The Big Deal: Usually, "chemo" is like carpet-bombing a city to hit one house. This is like a precision-guided strike that melts the house from the inside, triggering a secondary immune response that hunts down any "escapee" cancer cells.
🌊 The Domino Effect: If INT230-6 proves safe in late-stage trials, then systemic chemotherapy might become a "Plan B" for solid tumors, radically reducing side effects like hair loss and organ damage.
🧠 Inventor vs. 💰 Investor: Lewis H. Bender (Founder/Inventor) spent years convincing people that "poking the tumor" was better than poisoning the patient; the investors are now holding a patent that turns a "deadly cancer" into a manageable "chronic condition."

Karyopharm: The Spleen-Shrinking Synergy
🔬 The Tech: Validated IP covering the combination of Selinexor (XPO1 inhibitor) and Ruxolitinib for treating Myelofibrosis, specifically achieving a 35% reduction in spleen volume (SVR35).
🏋️♂️ Patent Strength: 8.7/10 (Clinical validation of the primary endpoint adds "defensive" utility to the existing IP).
🚀 The Big Deal: Myelofibrosis makes the spleen grow so large it feels like you're carrying a bowling ball in your gut. This combo effectively "deflates" it twice as fast as current standard treatments.
🌊 The Domino Effect: If SVR35 correlates with overall survival, as the data suggests, this combination becomes the new "gold standard," effectively pushing competitors out of the frontline treatment market.
🧠 Inventor vs. 💰 Investor: The research team at Mount Sinai found the synergy; the investors are currently balancing a "promising survival signal" against the missed secondary symptom endpoint—a classic biotech cliffhanger.

Shih Mo’s "Early Warning" Stroke Wearable
🔬 The Tech: A 4G/5G-enabled Early Stroke-Detection Device that uses integrated sensors to detect micro-fluctuations in neurological motor patterns before a major event occurs.
🏋️♂️ Patent Strength: 7.1/10 (Strong utility for remote patient monitoring).
🚀 The Big Deal: Strokes are the "silent thieves" of health. This device turns your wrist into a 24/7 neurologist, potentially saving billions in long-term disability costs.
🌊 The Domino Effect: If wearable stroke detection becomes standard, insurance companies will likely mandate them for "at-risk" populations to avoid the $100k+ costs of emergency ICU care..
🧠 Inventor vs. 💰 Investor: Shih Mo (4G/5G Pioneer) applied his telecom expertise to biology; investors are looking for the "exit" via a Medtronic or Apple acquisition.

Advertisement
Transform Internal Comms Chaos Into Clarity
Simplify internal comms with Haystack. Publish updates, maintain approval workflows, and track engagement—all from a single platform designed to reduce chaos and keep employees aligned.
⚡ ENERGY & MATERIALS
Patents in Motion: Assessing this week's highlighted tickers:
Stockholm University: The "Liquid-Liquid" Water State
🔬 The Tech: Breakthrough research using ultra-short X-ray pulses to identify a critical point in supercooled water at -63°C, allowing for the control of water's "strange" density fluctuations.
🏋️♂️ Patent Strength: N/A (Academic Breakthrough), but sets the stage for future cryopreservation patents.
🚀 The Big Deal: Understanding why water expands when it freezes (and how to stop it) is the "Holy Grail" for cryogenics and long-term biological storage.
🌊 The Domino Effect: If we can manipulate this critical point, then "flash-freezing" human organs for transplant without ice-crystal damage moves from science fiction to a business plan.
🧠 Inventor vs. 💰 Investor: Professor Anders Nilsson wanted to settle a century-old physics debate; investors in the organ-transplant logistics space are now looking at how to patent the cooling hardware.

Spin-Flip "130% Efficiency" Solar Cells
🔬 The Tech: Use of a spin-flip metal complex to achieve "singlet fission," where one high-energy photon is multiplied into two electrons, breaking the theoretical Shockley-Queisser limit of 33.7%.
🏋️♂️ Patent Strength: 8.2/10 (Foundational physical process patent).
🚀 The Big Deal: We’ve finally cheated at physics. Most solar cells throw away half the energy they touch; these cells squeeze every last drop out of the spectrum.
🌊 The Domino Effect: If efficiency hits the 40%+ mark at scale, coal and gas aren't just "unethical"—they become mathematically impossible to justify on a balance sheet.
🧠 Inventor vs. 💰 Investor: The scientists are celebrating a "singlet fission" miracle; the investors are just asking, "How many years until we can put this on a roof in Arizona?"

NewHydrogen: The Isothermal "Hydrogen Shortcut"
🔬 The Tech: A breakthrough thermochemical water-splitting process titled "Coupled Multi-phase Oxidation-Reducing For Production of Chemicals." Unlike traditional thermochemical cycles that require massive, energy-draining temperature swings (heating to 1,500°C then cooling to 800°C), this "ThermoLoop" technology uses AI-discovered mixed-metal oxides to maintain a near isothermal (constant temperature) state. By exploiting phase-change properties of these materials, the system splits water into hydrogen and oxygen at temperatures below 1,000°C.
🏋️♂️ Patent Strength: 9.2/10 (International PCT filing covering 158 countries; joint ownership with the University of California, Santa Barbara).
🚀 The Big Deal: Currently, "Green Hydrogen" is expensive because it relies on electrolysis—essentially using expensive electricity to rip water apart. ThermoLoop skips the electricity and uses direct heat. By operating below 1,000°C, it can plug directly into existing industrial waste heat, concentrated solar, or Small Modular Reactors (SMRs), potentially cutting hydrogen production costs by 73%.
🌊 The Domino Effect: If 1,000°C isothermal production scales, then the $12 trillion hydrogen economy stops being a PowerPoint fantasy. Heavy industries like steel and glass can use their own waste heat to generate the fuel they need, crashing the demand for grid-heavy electrolyzers.
🧠 Inventor vs. 💰 Investor: Dr. Eric McFarland (CTO/Inventor) is the academic powerhouse from UCSB providing the thermodynamic "magic"; Steve Hill (CEO/Investor) is the strategist positioning this as an "electrolyzer killer" to attract the massive capital needed to move from benchtop prototype to industrial scale.

Advertisement
Attio is the AI CRM for modern teams.
Connect your email and calendar and Attio instantly builds your CRM. Every contact, every company, every conversation — organized in one place. Then ask it anything. No more digging, no more data entry. Just answers.
🚀 AEROSPACE & DEFENSE
Patents in Motion: Assessing this week's highlighted tickers:
Textron eAviation: The "Redundant Heart" for eVTOLs
🔬 The Tech: U.S. Patent No. 12,583,598 covers a Fail-Safe Power Distribution System specifically for multi-rotor aircraft. The system uses a cross-linked architecture where primary batteries and power distribution units (PDUs) are dedicated to specific rotor pairs (e.g., front-left and front-right). If one battery decides to "retire" mid-flight, the system reconfigures power flow to ensure the aircraft remains balanced rather than performing an unscheduled gymnastic routine.
🏋️♂️ Patent Strength: 9.1/10 (A B1 "fast-track" grant that effectively sets the safety standard for the upcoming urban air mobility market).
🚀 The Big Deal: For "flying taxis" to get FAA certified, they can't just be cool; they have to be boringly safe. This patent provides the electrical redundancy required to keep an air taxi stable even during a catastrophic battery failure.
🌊 The Domino Effect: If Textron’s redundancy logic becomes the industry gold standard, then every other eVTOL startup (Joby, Archer) will either have to license this IP or find a way to break the laws of physics to prove their own systems are just as safe.
🧠 Inventor vs. 💰 Investor: Logan Bryant and the engineering team at Textron eAviation (Inventors) solved the "single point of failure" nightmare; the investors are now sitting on a piece of IP that makes Textron a gatekeeper for the entire $1 trillion Urban Air Mobility (UAM) sector.

Oshkosh Defense: The "Belly Armor" for Electric War-Wagons
🔬 The Tech: U.S. Patent No. 12,584,715 describes a Hybrid Vehicle Battery Armor Assembly. It features a specialized "sandwich" design where the battery unit is encased between inner and outer high-strength plates, then coupled to the exterior of the vehicle's belly deflector (the V-hull). This protects the volatile lithium-ion cells from both IED blasts from below and mechanical stress from the terrain.
🏋️♂️ Patent Strength: 8.8/10 (Strong utility grant that bridges the gap between traditional armor and the new requirements of electrified tactical vehicles).
🚀 The Big Deal: You can't just slap a Tesla battery into a Humvee and call it a day. If a battery is punctured in a combat zone, it becomes a secondary weapon against the crew. Oshkosh’s armor ensures the "fuel" of the future doesn't become the fire of the present.
🌊 The Domino Effect: If the U.S. Army moves toward a fully hybrid or electric fleet, Oshkosh’s patented armor mounting system becomes a mandatory "safety feature," potentially securing them decades of sole-source sustainment contracts.
🧠 Inventor vs. 💰 Investor: Chad Smith and his team (Inventors) figured out how to make a 1,000lb battery survive a landmine; the investors are enjoying a defensive moat that makes it very difficult for non-traditional EV makers to break into the armored vehicle market.

Raytheon: The "Cold Launch" Vacuum Shield
🔬 The Tech: U.S. Patent No. 12,560,406 introduces a Vacuum Insulated Vertical Launch System (VLS). It uses integrated vacuum layers within the walls of missile canisters to provide thermal conductivity less than one-third that of air. This prevents the "cook-off" of sensitive energetic materials (missile fuel) when launchers are packed in ultra-dense, high-temperature configurations on ships or in silos.
🏋️♂️ Patent Strength: 8.5/10 (A critical "enabling technology" for the Navy’s push toward more compact, high-capacity missile magazines).
🚀 The Big Deal: Modern ships want to carry more missiles in smaller spaces. The problem? Heat from one launching missile can desensitize or detonate the one next to it. Raytheon’s vacuum "thermos" design allows for much denser—and therefore deadlier—missile arrays.
🌊 The Domino Effect: If vacuum insulation allows for a 30% increase in missile density per hull, then the Navy can effectively "up-arm" existing destroyers without building new ships, saving billions in shipbuilding costs.
🧠 Inventor vs. 💰 Investor: John Rascon and Christopher Schott (Inventors) applied the physics of a YETI tumbler to a missile silo; the investors are looking at a patent that solidifies Raytheon's dominance in the $10B+ global VLS market.

Sponsored Content
Wall Street's Scared—You Should Be Buying
Markets are down, but smart money is circling.
In under 5 minutes, you’ll discover three battered but fundamentally strong picks with massive upside as conditions normalize.
These aren’t flavor-of-the-month names. They're backed by long-term trends, strong leadership, and ideal entry points created by panic selling.
The dip is real. The opportunity is rare. With AI, cyclical rebounds, and broad exposure, this report gives you an actionable edge. Get in before Wall Street catches on.
🛍️ RETAIL, UX & LOGISTICS
Patents in Motion: Assessing this week's highlighted tickers:
Amazon: The "Airborne Traffic Controller" for Drone Swarms
🔬 The Tech: U.S. Patent No. 12,583,901 covers an Automated Aerial Traffic Management System. This involves a decentralized network where delivery drones communicate directly with each other—bypassing a central hub—to negotiate flight paths, avoid "aerial fender benders," and prioritize emergency landings based on battery health and package urgency.
🏋️♂️ Patent Strength: 9.5/10 (A foundational "network effect" patent that makes Amazon the de facto architect of the low-altitude sky).
🚀 The Big Deal: We’re moving from "one pilot, one drone" to "ten thousand drones, zero pilots." This tech ensures that when your organic kale is flying over the suburbs, it doesn't collide with your neighbor’s new pair of sneakers.
🌊 The Domino Effect: If drones can safely negotiate their own traffic, then the "last mile" delivery cost drops by 80%, making 30-minute delivery the standard for everything from burritos to blood pressure medication.
🧠 Inventor vs. 💰 Investor: The Amazon Prime Air engineers (Inventors) solved the 3D geometry of chaos; the investors are salivating over the prospect of firing half the delivery van fleet and replacing them with electricity-sipping quadcopters.

Walmart: The "Predictive Pantry" Biometric Cart
🔬 The Tech: The patent application US 2018/0240554 A1 (titled "System and Method for a Biometric Feedback Cart Handle") describes a Haptic-Feedback Retail Cart with Biometric Sensing. The handle of the cart measures the shopper's heart rate, grip strength, and even skin temperature. Using AI, it compares these "stress signals" against the items being scanned to determine if a customer is frustrated, confused, or—most importantly—ready to be nudged toward a high-margin impulse buy.
🏋️♂️ (Potential) Patent Strength: 8.7/10 (A sophisticated blend of hardware and behavioral psychology that is very hard for competitors to "work around").
🚀 The Big Deal: Walmart is literally taking your pulse. If your grip tightens while looking at a generic brand, the cart might vibrate a 10% coupon for the name-brand version onto your phone. It’s retail therapy, but the therapist is an AI.
🌊 The Domino Effect: If biometric shopping catches on, "brick-and-mortar" stores will finally have the same data-granularity as Amazon, allowing them to dynamic-price items in real-time based on how much you want them.
🧠 Inventor vs. 💰 Investor: Nicholaus A. Jones and his team (Inventors) turned a shopping cart into a polygraph machine; the investors see this as the ultimate weapon to increase "basket size" and salvage the margins of physical retail.

Apple: The "Intent-Aware" Invisible Interface
🔬 The Tech: Apple’s patent applications covers Anticipatory User Interface Generation based on Gaze and Gesture. Using the Vision Pro’s sensor suite, the OS doesn't wait for you to click; it renders interface elements before you touch them by predicting your intent based on the micro-movements of your pupils and the heat signatures of your fingertips.
🏋️♂️ (Potential) Patent Strength: 9.8/10 (Samsung leads in volume, but Apple owns the "Human-Computer Interaction" gold standard)
🚀 The Big Deal: We are witnessing the death of the "Button." If the computer knows what you want before you do, the friction of "using" technology disappears. The interface becomes an extension of your nervous system.
🌊 The Domino Effect: As production scales through 2026, this technology targets the US$80+ billion non-cellular plastic film market. By utilizing seaweed alginates and birch cellulose—which require no freshwater or pesticides—the supply chain shifts from fossil-fuel extraction to regenerative "forest-to-film" systems, allowing marine ecosystems to begin their recovery.
🧠 Inventor vs. 💰 Investor: If "Intent-UX" becomes the standard, then keyboards and mice become the "pagers" of 2030—clunky relics of a time when we had to explain ourselves to our machines.

Recommendations
The Patent Ticker: Because by the time it's on a shelf, the money's already been made.
The Fine Print: The inventors are busy, the investors are greedy, and the patents are rolling in. A patent today doesn’t guarantee a profit tomorrow. IDiyas is a data and information platform, not a financial advisor. While we love tracking innovation, this newsletter is for educational purposes only. Always conduct your own due diligence before making any financial moves.




